Speakers and Moderators


Nicolas Acquavella
Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

Lorenzo Borgognoni
Plastic Surgery Unit, Regional Melanoma Referral Center, SM Annunziata Hospital, Tuscan Tumor Institute, Florence, Italy

Vincent Brichard
Vice President & Head of Immunotherapeutics at GlaxoSmithKline Biologicals, Belgium

Luana Calabrò
Medical Oncology and Immunotherapy, University Hospital, Siena, Italy

Alessandra Cesano
Clinical Affairs, Nodality Inc., South San Francisco, California  

Michele Del Vecchio
Unit of Medical Oncology 1, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy  

Lex Eggermont
Institut de Cancérologie Gustave Roussy, Villejuif, Paris-Sud, France  

Mark Faries
Department of Surgical Oncology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, California

Soldano Ferrone
University of Pittsburgh Cancer Institute, Pennsylvania  

Thomas F. Gajewski
Department of Pathology and Department of Medicine, Section of Hematology/Oncology,University of Chicago, Chicago, Illinois  

Sacha Gnjatic
Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center, New York City, New York

Helen Gogas
1st Department of Medicine, "Laiko" General Hospital, University of Athens, Greece  

Mohamed Kashani-Sabet
Center for Melanoma Research and Treatment, California Pacific Medical Center and CPMC Research Institute, San Francisco, California

Howard Kaufman
The Tumor Immunology Laboratory & Department of General Surgery, Rush University Medical Center, Chicago, Illinois

James Larkin
Department of Medicine, The Royal Marsden Hospital, London, UK

Paul V. Lehmann
CEO of Cellular Technology Ltd and Adjunct Professor at CWRU, Cleveland, Ohio

Roger Lo
Assistant Professor of Medicine/Dermatology & Molecular and Medical Pharmacology Director, Melanoma Clinic in Dermatology Member, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA

Alberto Mantovani
Istituto Clinico Humanitas IRCCS and Dept. Translational Medicine, University of Milan, Italy  

Kim Margolin
Medical Oncology, University of Washington, Seattle, Washington

Grant McArthur
Divisions of Cancer Medicine and Cancer Research, Peter MacCallum Cancer Centre, Victoria, Australia  

Cornelis Melief
Leiden University Medical center and Immune system Activation (ISA) Pharma, Leiden, The Netherlands

Igor Puzanov
Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee

Nicola Normanno
Cell Biology and Biotherapy Unit, INT Fondazione G. Pascale, Naples, Italy

Rienk Offringa
Head Div. Molecular Oncology of Gastrointestinal Cancers, German Cancer Research Center, Heidelberg, Germany

Paola Queirolo
San Martino Hospital, National Institute for Cancer Research, Genoa, Italy

Licia Rivoltini
Unit of Immunotherapy of Human Tumours, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy

Barbara Seliger
Institute of Medical Immunology, Martin-Luther-University Halle-Wittenberg, Saale, Germany

Jeff Sosman
Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee

Magdalena Thurin
Cancer Diagnosis Program, NCI, NIH, Rockville, Maryland






For information please contact info@melanomabridge.org